This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2024 Apr;80(4):e171-e172.

doi: 10.1016/j.jhep.2023.09.034. Epub 2023 Oct 10.

Incorporating AFP-L3 and DCP in selecting patients with hepatocellular carcinoma for liver transplantation: What are the optimal criteria?

Meng Sha¹, Jie Cao², Qiang Xia³

Affiliations

Affiliations

¹ Department of Liver Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China. Electronic address: simonsha23@163.com.
² Department of Liver Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China.
³ Department of Liver Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China. Electronic address: xiaqiang@shsmu.edu.cn.

PMID: 37821020
DOI: 10.1016/j.jhep.2023.09.034

Comment

Incorporating AFP-L3 and DCP in selecting patients with hepatocellular carcinoma for liver transplantation: What are the optimal criteria?

Meng Sha et al. J Hepatol. 2024 Apr.

. 2024 Apr;80(4):e171-e172.

doi: 10.1016/j.jhep.2023.09.034. Epub 2023 Oct 10.

Authors

Meng Sha¹, Jie Cao², Qiang Xia³

Affiliations

¹ Department of Liver Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China. Electronic address: simonsha23@163.com.
² Department of Liver Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China.
³ Department of Liver Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China. Electronic address: xiaqiang@shsmu.edu.cn.

PMID: 37821020
DOI: 10.1016/j.jhep.2023.09.034

No abstract available

PubMed Disclaimer

Comment in

Reply to: "Incorporating AFP-L3 and DCP in selecting patients with hepatocellular carcinoma for liver transplantation: What are the optimal criteria?".
Norman JS, Mehta N. Norman JS, et al. J Hepatol. 2024 Apr;80(4):e172-e173. doi: 10.1016/j.jhep.2023.12.017. Epub 2023 Dec 26. J Hepatol. 2024. PMID: 38154740 No abstract available.

Comment on

AFP-L3 and DCP strongly predict early hepatocellular carcinoma recurrence after liver transplantation.
Norman JS, Li PJ, Kotwani P, Shui AM, Yao F, Mehta N. Norman JS, et al. J Hepatol. 2023 Dec;79(6):1469-1477. doi: 10.1016/j.jhep.2023.08.020. Epub 2023 Sep 7. J Hepatol. 2023. PMID: 37683735 Free PMC article.

References

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information
Miscellaneous
- NCI CPTAC Assay Portal